• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨大垂体腺瘤的显微镜下经蝶窦切除术:73例切除程度限制因素分析

Microscopic Transsphenoidal Resection of Giant Pituitary Adenomas: Analysis of the Factors Limiting the Degree of Resection in 73 Cases.

作者信息

Pei Zhijie, Wang Jiaxing, Mu Shuwen, Feng Tianshun, Wang Meina, Yu Shentong, Wei Liangfeng, Fang Yi, Wang Shousen

机构信息

Department of Neurosurgery, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.

Department of Neurosurgery, The First Hospital of Yichang, The People's Hospital of China Three Gorges University, Yichang, China.

出版信息

Front Neurol. 2022 May 27;13:880732. doi: 10.3389/fneur.2022.880732. eCollection 2022.

DOI:10.3389/fneur.2022.880732
PMID:35711254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9195514/
Abstract

PURPOSE

To analyze the risk factors affecting the gross-total resection of giant pituitary adenomas using a transsphenoidal approach under a microscope to provide a reference basis for formulating an appropriate surgical strategy.

METHODS

The clinical data of patients who underwent microscopic transsphenoidal resection of giant pituitary adenomas in a single center from January 2011 to December 2020 were retrospectively analyzed. Based on magnetic resonance imaging and surgical records, the predictive factors affecting the gross-total resection of giant pituitary adenomas under microscopy were determined through univariate and multivariate analyses.

RESULTS

A total of 73 patients with giant pituitary adenomas underwent transsphenoidal microsurgery. Gross-total resection was performed in 19 cases (26%), subtotal resection in 31 cases (42%), partial resection in 21 cases (29%), and the degree of resection was <50% in only two cases (3%). After binary logistic analysis, it was found that it was more difficult to completely remove giant pituitary adenomas with a Knosp grade 3-4 [odds ratio (OR) = 0.214, 95% confidence interval (CI): 0.05-0.917; = 0.038], greater proportion of tumor suprasellar volume (odds ratio = 0.937, 95% confidence interval: 0.898-0.978; = 0.003), and intraoperative evidence of invasion of the cavernous sinus (odds ratio = 0.187, 95% CI: 0.039-0.898; = 0.036).

CONCLUSION

It is difficult to remove a giant pituitary adenoma invading the cavernous sinus completely with a higher degree of invasion of the suprasellar region using microscopic transsphenoidal surgery. The combined application of multiple surgical methods can help to improve the degree of resection during a single operation.

摘要

目的

分析显微镜下经蝶入路切除巨大垂体腺瘤全切除的危险因素,为制定合适的手术策略提供参考依据。

方法

回顾性分析2011年1月至2020年12月在单中心接受显微镜下经蝶窦切除巨大垂体腺瘤患者的临床资料。基于磁共振成像和手术记录,通过单因素和多因素分析确定影响显微镜下巨大垂体腺瘤全切除的预测因素。

结果

共有73例巨大垂体腺瘤患者接受经蝶窦显微手术。19例(26%)行全切除,31例(42%)行次全切除,21例(29%)行部分切除,仅2例(3%)切除程度<50%。二元逻辑回归分析后发现,Knosp 3-4级的巨大垂体腺瘤更难完全切除[比值比(OR)=0.214,95%置信区间(CI):0.05-0.917;P=0.038],肿瘤鞍上体积占比更大(比值比=0.937,95%置信区间:0.898-0.978;P=0.003),以及术中存在海绵窦侵犯证据(比值比=0.187,95%CI:0.039-0.898;P=0.036)。

结论

对于侵犯海绵窦且鞍上区域侵犯程度较高的巨大垂体腺瘤,显微镜下经蝶窦手术难以完全切除。多种手术方法联合应用有助于提高单次手术的切除程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/525a/9195514/be989be36af0/fneur-13-880732-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/525a/9195514/02635467a920/fneur-13-880732-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/525a/9195514/b739f68de013/fneur-13-880732-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/525a/9195514/be989be36af0/fneur-13-880732-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/525a/9195514/02635467a920/fneur-13-880732-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/525a/9195514/b739f68de013/fneur-13-880732-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/525a/9195514/be989be36af0/fneur-13-880732-g0003.jpg

相似文献

1
Microscopic Transsphenoidal Resection of Giant Pituitary Adenomas: Analysis of the Factors Limiting the Degree of Resection in 73 Cases.巨大垂体腺瘤的显微镜下经蝶窦切除术:73例切除程度限制因素分析
Front Neurol. 2022 May 27;13:880732. doi: 10.3389/fneur.2022.880732. eCollection 2022.
2
Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.经鼻内镜蝶窦入路切除大型和巨大型垂体腺瘤:机构经验和影响切除程度的预测因素。
J Neurosurg. 2014 Jul;121(1):75-83. doi: 10.3171/2014.3.JNS131679. Epub 2014 May 2.
3
Characterization of tumor remnants in intraoperative MRI-assisted microscopic and endoscopic transsphenoidal resection of less invasive pituitary adenomas.术中磁共振成像辅助下显微镜和经鼻内镜经蝶窦微创手术切除侵袭性较小的垂体腺瘤后肿瘤残余的特征。
Neurosurg Rev. 2022 Apr;45(2):1701-1708. doi: 10.1007/s10143-021-01705-z. Epub 2021 Dec 2.
4
Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases.经蝶窦入路扩大切除侵犯颅前窝底、海绵窦和斜坡的垂体腺瘤:单中心 126 例连续病例经验。
J Neurosurg. 2010 Jan;112(1):108-17. doi: 10.3171/2009.3.JNS0929.
5
The Value of Intraoperative Magnetic Resonance Imaging in Endoscopic and Microsurgical Transsphenoidal Pituitary Adenoma Resection.术中磁共振成像在内镜及显微经蝶垂体腺瘤切除术中的价值
World Neurosurg. 2017 Jun;102:144-150. doi: 10.1016/j.wneu.2017.02.132. Epub 2017 Mar 9.
6
Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery.经术中磁共振成像辅助的经蝶窦垂体手术 10 年经验。
Neurosurg Focus. 2020 Jun;48(6):E14. doi: 10.3171/2020.3.FOCUS2072.
7
Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery.对于内镜经蝶窦手术中具有鞍上延伸的垂体腺瘤,前后径是可切除性和并发症的关键驱动因素。
Pituitary. 2023 Oct;26(5):629-641. doi: 10.1007/s11102-023-01354-z. Epub 2023 Sep 15.
8
Transsphenoidal Surgery of Giant Pituitary Adenoma: Results and Experience of 239 Cases in A Single Center.经蝶窦手术治疗巨大垂体腺瘤:单中心 239 例经验及结果
Front Endocrinol (Lausanne). 2022 May 6;13:879702. doi: 10.3389/fendo.2022.879702. eCollection 2022.
9
Transsphenoidal Surgery of Corticotroph Adenomas With Cavernous Sinus Invasion: Results in a Series of 86 Consecutive Patients.经蝶窦手术治疗侵犯海绵窦的促肾上腺皮质激素腺瘤:86例连续病例的结果
Front Oncol. 2022 Feb 8;12:810234. doi: 10.3389/fonc.2022.810234. eCollection 2022.
10
Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.经鼻内镜垂体腺瘤术后残留或复发的再次手术治疗。
J Neurosurg. 2017 Aug;127(2):397-408. doi: 10.3171/2016.8.JNS152709. Epub 2016 Oct 28.

引用本文的文献

1
Comparison of Clinical Outcomes between Microscopic and Endoscopic Transsphenoidal Pituitary Tumor Resection.显微镜下经蝶窦垂体肿瘤切除术与内镜下经蝶窦垂体肿瘤切除术临床结果的比较。
J Neurol Surg B Skull Base. 2024 Jul 23;86(4):419-428. doi: 10.1055/s-0044-1788582. eCollection 2025 Aug.
2
Endoscopic and exoscopic surgery for brain tumors.脑肿瘤的内镜和外科学手术。
Int J Clin Oncol. 2024 Oct;29(10):1399-1406. doi: 10.1007/s10147-024-02529-9. Epub 2024 Jul 8.

本文引用的文献

1
Outcomes and surgical nuances in management of giant pituitary adenomas: a review of 108 cases in the endoscopic era.巨大垂体腺瘤治疗的结果与手术细节:内镜时代108例病例回顾
J Neurosurg. 2022 Jan 21;137(3):635-646. doi: 10.3171/2021.10.JNS21659. Print 2022 Sep 1.
2
Endoscopic approach for giant pituitary adenoma: clinical outcomes of 205 patients and comparison of two proposed classification systems for preoperative prediction of extent of resection.内镜经鼻入路切除巨大垂体腺瘤:205 例患者的临床结果,并比较两种术前预测肿瘤全切除程度的分类系统。
J Neurosurg. 2021 Sep 17;136(3):786-800. doi: 10.3171/2021.3.JNS204116. Print 2022 Mar 1.
3
Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta-analysis.
Knosp分级及改良Knosp分级对垂体腺瘤海绵窦侵犯的诊断价值:一项系统评价和Meta分析
Pituitary. 2021 Jun;24(3):457-464. doi: 10.1007/s11102-020-01122-3. Epub 2021 Jan 25.
4
Clinical Outcomes After Endoscopic Endonasal Resection of Giant Pituitary Adenomas.经鼻内镜切除巨大垂体腺瘤后的临床结局
World Neurosurg. 2018 Jun;114:e447-e456. doi: 10.1016/j.wneu.2018.03.006. Epub 2018 Mar 12.
5
Large and giant pituitary adenoma resection by microscopic trans-sphenoidal surgery: Surgical outcomes and complications in 123 consecutive patients.经显微镜下经蝶窦手术切除大型及巨大垂体腺瘤:123例连续患者的手术结果及并发症
J Clin Neurosci. 2017 Oct;44:310-314. doi: 10.1016/j.jocn.2017.07.015. Epub 2017 Aug 1.
6
Inherent Tumor Characteristics That Limit Effective and Safe Resection of Giant Nonfunctioning Pituitary Adenomas.限制巨大无功能垂体腺瘤有效及安全切除的内在肿瘤特征。
World Neurosurg. 2017 Oct;106:645-652. doi: 10.1016/j.wneu.2017.07.043. Epub 2017 Jul 19.
7
How to deal with giant pituitary adenomas: transsphenoidal or transcranial, simultaneous or two-staged?如何处理巨大垂体腺瘤:经蝶窦还是经颅,一期还是分期?
J Neurooncol. 2017 Apr;132(2):313-321. doi: 10.1007/s11060-017-2371-6. Epub 2017 Jan 11.
8
Endoscopic versus microscopic transsphenoidal surgery in the treatment of pituitary tumors: systematic review and meta-analysis of randomized and non-randomized controlled trials.内镜与显微镜下经蝶窦手术治疗垂体瘤:随机和非随机对照试验的系统评价与荟萃分析
Arch Endocrinol Metab. 2016 Oct;60(5):411-419. doi: 10.1590/2359-3997000000204. Epub 2016 Sep 5.
9
Cavernous sinus invasion by pituitary adenomas: role of endoscopic endonasal surgery.垂体腺瘤侵犯海绵窦:鼻内镜手术的作用
J Neurosurg Sci. 2016 Dec;60(4):485-94. Epub 2016 Jun 9.
10
The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.转录因子在临床无功能垂体腺瘤准确诊断中的互补作用
Endocr Pathol. 2015 Dec;26(4):349-55. doi: 10.1007/s12022-015-9398-z.